Sengul, N. Et Al. 2024. Safety and efficacy of nivolumab therapy in patients with metastatic renal cell carcinoma and impaired kidney function.. Actas urologicas espanolas , vol.48, no.4 , 273-280.

Sengul, N., Gültürk, I., Yilmaz, M., Celik, E., Paksoy, N., Yekedüz, E., ... Ürün, Y.(2024). Safety and efficacy of nivolumab therapy in patients with metastatic renal cell carcinoma and impaired kidney function.. Actas urologicas espanolas , vol.48, no.4, 273-280.

Sengul, N Et Al. "Safety and efficacy of nivolumab therapy in patients with metastatic renal cell carcinoma and impaired kidney function.," Actas urologicas espanolas , vol.48, no.4, 273-280, 2024

Sengul, N Et Al. "Safety and efficacy of nivolumab therapy in patients with metastatic renal cell carcinoma and impaired kidney function.." Actas urologicas espanolas , vol.48, no.4, pp.273-280, 2024

Sengul, N. Et Al. (2024) . "Safety and efficacy of nivolumab therapy in patients with metastatic renal cell carcinoma and impaired kidney function.." Actas urologicas espanolas , vol.48, no.4, pp.273-280.

@article{article, author={N Sengul Et Al. }, title={Safety and efficacy of nivolumab therapy in patients with metastatic renal cell carcinoma and impaired kidney function.}, journal={Actas urologicas espanolas}, year=2024, pages={273-280} }